Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 91596

AbstractCase ReportDiscussionConclusionReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"

Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018

Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."

Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018

Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."

Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018

Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."

Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
On Sep 2018

Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."

Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata

Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
On Aug 2018

Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".

Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
On Aug 2018

Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".

Dr. Mamta Gupta
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018

Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.

Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."

Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
On May 11,2011

Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."

Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
On April 2011

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.

Dr. Anuradha
On Jan 2020

Important Notice

Case report
Year : 2023 | Month : September | Volume : 17 | Issue : 9 | Page : QD01 - QD04 Full Version

Endometrial Stromal Sarcoma in a Young, Nulliparous Woman: A Case Report

Published: September 1, 2023 | DOI:
S Subhasri, K Nivedita, N Noorul Nasheeha, K Rajkumar, V Sriram

1. Junior Resident, Department of Obstetrics and Gynaecology, Sri Manakular Vinayagar Medical College and Hospita,l Puducherry, India. 2. Professor, Department of Obstetrics and Gynaecology, Sri Manakular Vinayagar Medical College and Hospital, Puducherry, India. 3. Assistant Professor, Department of Obstetrics and Gynaecology, Sri Manakular Vinayagar Medical College and Hospital, Puducherry, India. 4. Assistant Professor, Department of Oncosurgery, Sri Manakular Vinayagar Medical College and Hospital, Puducherry, India. 5. Associate Professor, Department of Pathology, Sri Manakular Vinayagar Medical College and Hospital, Puducherry, India.

Correspondence Address :
S Subhasri,
Department of Obstetrics and Gynaecology, Sri Manakular Vinayagar Medical College and Hospital, Puducherry, India


Endometrial stromal tumours are tumours of endometrial stromal origin and are classified into Endometrial Stromal Nodule (ESN), Low-Grade Endometrial Stromal Sarcoma (LG-ESS), and High-Grade Endometrial Stromal Sarcoma (HG-ESS). LG-ESS and HG-ESS are rare tumours, accounting for 1% of uterine malignancies and 10% of uterine sarcomas. These tumours commonly occur in perimenopausal women between the ages of 45 and 50 years. Their incidence is rare in younger women. Endometrial stromal tumours are usually confused with leiomyoma, uterine Leiomyosarcoma (LMS), or other sarcomas. The authors here present a case report of a 28-year-old nulligravid patient who presented with a history of heavy menstrual bleeding and dysmenorrhea for a duration of six months. Ultrasonography of the abdomen and pelvis suggested fibroid with degenerative changes, and Magnetic Resonance Imaging (MRI) indicated leiomyoma variants such as: i) Stromal Tumours of Uncertain Malignant Potential (STUMP)/atypical/cellular leiomyoma; ii) myxoid degeneration of leiomyoma. To arrive at a definitive diagnosis, myomectomy was performed considering the woman’s young age and nulliparity. Histopathology allowed for a differential diagnosis of LG-ESS, LMS, and cellular leiomyoma. Consequently, the patient underwent total abdominal hysterectomy with left salphingo opherectomy, right salpingectomy, and preservation of the right ovary. The definitive diagnosis is made by histopathological examination coupled with immunohistochemistry of the hysterectomy specimen. Hysterectomy is the definitive treatment of LG-ESS considering their ability to infiltrate and become malignant.


Uterine malignancy, Leiomyosarcoma, Low grade

Case Report

A 28-year-old nulligravida presented with a history of heavy menstrual bleeding and dysmenorrhea for a duration of six months. She attained menarche at the age of 14, with regular and normal menstrual cycles. She has no history of contraceptive use or any significant medical or family history. Upon presentation at the hospital, she did not appear pale, and no palpable abdominal mass was found. As she was not sexually active, a bimanual examination was deferred.

Ultrasonography of the abdomen and pelvis showed a heterogeneous mixed solid to cystic lesion in the uterus, suggestive of fibroid with degenerative changes. Magnetic Resonance Imaging (MRI) of the abdomen and pelvis revealed a bulky uterus measuring 10.4×8.7×9.9 cm, with a well-encapsulated heterogeneous lesion predominantly hyperintense on both T1 and T2, with a peripheral T2 hypointense rim arising from the posterior and left lateral wall of the uterus. There was no suppression on fat saturation images, no blooming on gradient images, no pelvic/para-aortic lymphadenopathy, and no ascites. The differential diagnosis included: i) leiomyoma variants like STUMP/atypical/cellular leiomyoma; ii) myxoid degeneration of leiomyoma [Table/Fig-1-3]. Given these findings, she underwent examination under anaesthesia and hysteroscopic-guided endometrial biopsy.

During bimanual examination, a uterus of 14 weeks in size and a posterior wall fibroid measuring 5×5 cm felt through the pouch of Douglas were noted. Hysteroscopic-guided endometrial biopsy revealed a thickened polypoidal endometrium, and the histopathological report indicated endometrial hyperplasia without atypia. Considering the woman’s young age and nulliparity, myomectomy was performed to arrive at a definitive diagnosis. Intraoperative findings revealed a posterior uterine wall tumour measuring 7×6 cm with variable consistency, which was enucleated in toto (Table/Fig 4). Grossly, the specimen had a yellowish tan color (Table/Fig 5). Microscopic examination revealed necrotic tissue with tumour cells arranged as nodules with interlacing fascicles of smooth muscle cells. The individual tumour cells were round to spindle-shaped with bland nuclear features and occasional mild atypia. One focus showed vascular and muscular invasion of tumour cells. The histopathological diagnosis included a differential diagnosis of LG-ESS, LMS, and cellular leiomyoma, and the patient was posted for definitive surgery.

Total abdominal hysterectomy with left salphingo opherectomy, right salpingectomy, and right ovarian preservation were performed. Microscopy showed tumour cells arranged in nodules and sheets infiltrating the myometrial wall for more than 50% of the myometrium. The tumour cells had round to oval hyperchromatic nuclei, with 8 to 12 mitoses per 10 high-power fields (Table/Fig 6),(Table/Fig 7). The tumour was involved in the blood vessels (Table/Fig 8). Additional immunohistochemistry studies revealed positive staining for CD10 (Table/Fig 9). HPE and immunohistochemistry with CD10 confirmed the diagnosis of LG-ESS. According to International Federation of Gynecology and Obstetrics (FIGO) staging, it was classified as Stage-Ib disease. The postoperative clinical course was uneventful. At the three-month follow-up visit, pelvic ultrasound, MRI pelvis, and chest X-ray were performed, and all were normal. The plan is to continue follow-up with clinical examination and the same investigations after six months, followed by annual check-ups.


Endometrial stromal sarcoma is a rare malignant tumour. It was first reported by Norris HJ and Taylor HB in 1966, who classified ESS into low-grade and high-grade types based on the mitotic index (1). According to the 2014 WHO classification, ESS is divided into four categories: ESN, LG-ESS, HG-ESS, and Undifferentiated Uterine Sarcoma (UUS) (2). LG-ESS and HG-ESS are rare malignancies, accounting for 1% of uterine malignancies and 10% of uterine sarcomas (3).

ESS most often affects perimenopausal women around 45 to 55 years. The presenting complaints are similar to leiomyoma of the uterus: abnormal uterine bleeding, abdominal pain, or pelvic mass. An enlarging pelvic mass can cause pressure, and some patients may be asymptomatic (4). Martinez M and Jacinto E reported a different presentation in the form of a polypoidal fleshy mass projecting through the cervix (5). This tumour has a high tendency for local recurrence and metastasis; and hence, an early diagnosis is important as patient survival is determined by the stage of the tumour (6).

The pathogenesis of ESS remains largely unknown, although specific somatic mutations have been discovered through cytogenetic, Fluorescence In Situ Hybridisation (FISH), and Polymerase Chain Reaction (PCR) analysis (7). Most ESS cases are characterised by an overexpression of estrogen and progesterone receptors (6). Diagnosing ESS is usually difficult preoperatively as it may be mistaken for leiomyoma, uterine LMS, or other sarcomas. The definitive diagnosis is made through histopathological examination coupled with immunohistochemistry of the hysterectomy specimen (8).

Ultrasonographic findings may be confused with uterine leiomyoma and adenomyosis. However, MRI can be used for a preoperative diagnosis with some accuracy. The lesion of endometrial stromal sarcoma is isointense relative to the myometrium on T1-weighted MRI and hyperintense on T2-weighted MRI. It also shows heterogeneous but prominent enhancement in contrast-enhanced images due to its rich vascularity (9). The characteristic findings of ESS on MRI are worm-like permeation of cancerous cells in the myometrium (9). The main tumour mass is almost always intramyometrial, but most ESS cases involve the endometrium. Uterine curettage may be helpful in preoperative diagnosis, but when the lesion is within the myometrium, the scrapings may not be useful (10).

The immunohistochemical markers, such as CD10, H-caldesmon, and hormone receptors, are helpful in the diagnosis. CD10 staining is positive in LG-ESS but not in HG-ESS and leiomyoma (11). These tumours are estrogen and progesterone receptor positive. CD10 has a sensitivity of 100% and specificity of 90%, while ER/PR shows a sensitivity and specificity of 80% and 100%, respectively, in diagnosing LG-ESS (12). In our patient, there was cytoplasmic positivity of CD10 staining, indicating a provisional diagnosis of LG-ESS.

The International Federation of Gynecology and Obstetrics staging of uterine sarcoma is used to determine the stage of ESS (13). Stage I is the most significant prognostic factor, and the 5-year Overall Survival (OS) rate for Stage I LG-ESS patients is more than 90%, but it decreases to 50% for Stage III and IV (14).

The treatment for LG-ESS involves total abdominal hysterectomy; however, ovary removal and pelvic and para-aortic lymphadenectomy remain debatable. Bilateral salphingo opherectomy has been recommended, even in premenopausal women with Stage I ESS disease, as it is a hormone-sensitive tumour, and the recurrence rate is high in women in whom ovaries were retained (15).

Recent reports suggest that preserving the ovaries may be possible in premenopausal women with Stage I ESS if the tumour is completely removed (16). Fertility-sparing treatment, along with adjuvant treatment, has been reported in cases of LG-ESS using local excision, hormone therapy, and photodynamic therapy (17). Studies have indicated that lymphadenectomy does not have a significant role in recurrence-free survival or OS in LG-ESS (16). Postoperative hormone therapy is an effective adjuvant treatment providing high local control and preventing recurrences. Hormone therapy with medroxyprogesterone, tamoxifen, Gonadotropin Releasing Hormone (GnRH) analogues, and aromatase inhibitors is suggested for LG-ESS stage 3-4 and recurrent disease (18).

The mechanism of action of progestins is to bind progesterone receptors and cause downregulation of gene transcription, leading to decreased endometrial gland and stromal proliferation (19). In our patient, the decision for hysterectomy was based on the currently available diagnostic tools and the lack of knowledge regarding the long-term consequences of conservative treatment.


Endometrial stromal sarcoma is a rarely encountered malignancy, especially in young individuals. Despite its rarity, ESS holds significant clinical importance due to the diagnostic and therapeutic challenges it presents. The authors reported this case to emphasize the need for a high level of suspicion and thorough evaluation of fibroid masses causing prolonged bleeding in young women, in order to promptly rule out malignancy at an early stage. The timely diagnosis and intervention are crucial for improving patient survival.


Norris HJ, Taylor HB. Mesenchymal tumours of the uterus. I. A clinical and pathological study of 53 endometrial stromal tumours. Cancer. 1966;19(6):755-66. 3.0.CO;2-U>[crossref][PubMed]
Nucci MR. Practical issues related to uterine pathology: Endometrial stromal tumours. Mod Pathol. 2016;29(Suppl 1):S92-103. 10.1038/modpathol.2015.140. [crossref][PubMed]
Seagle BL, Shilpi A, Buchanan S, Goodman C, Shahabi S. Low-grade and high-grade endometrial stromal sarcoma: A National Cancer Database study. Gynecol Oncol. 2017;146(2):254-62. [crossref][PubMed]
Fekete PS, Vellios F. The clinical and histologic spectrum of endometrial stromal neoplasm: A report of 41 cases. Int J Gynecol Pathol. 1984;3(2):198-212. [crossref][PubMed]
Martinez M, Jacinto E. Endometrial stromal sarcoma in the young. Journal of Clinical Gynecology and Obstetrics. 2020;9(3):73-77. [crossref]
Puliyath G, Nair MK. Endometrial stromal sarcoma: A review of the literature. Indian Journal of Medical and Paediatric Oncology. 2012;33(1):01-06. [crossref][PubMed]
Tropé CG, Abeler VM, Kristensen GB. Diagnosis and treatment of sarcoma of the uterus. A review. Acta Oncol. 2012;51(6):694-705. [crossref][PubMed]
Sohail R, Kanwal S, Murtaza A, Haq B. Endometrial stromal sarcoma in a 20-year-old woman. BMJ Case Rep. 2019;12(12):e228874. [crossref][PubMed]
Toprak U, Paşaoğlu E, Karademir MA, Gülbay M. Sonographic, CT, and MRI findings of endometrial stromal sarcoma located in the myometrium and associated with peritoneal inclusion cyst. AJR Am J Roentgenol. 2004;182(6):1531-33. [crossref][PubMed]
Ganjoei TA, Behtash N, Shariat M, Low AM. Grade endometrial stromal sarcoma of uterine corpus: A clinicopathological and survey study in 14 cases. World J Surg Oncol. 2006;4:50. Doi: 10.1186/1477-7819-4-50. [crossref][PubMed]
Subbaraya S, Murthy SS, Devi GS. Immunohistochemical and molecular characterization of endometrial stromal sarcomas. Clin Pathol. 2020;13:2632010X20916736. [crossref][PubMed]
Cui R, Yuan F, Wang Y, Li X, Zhang Z, Bai H. Clinicopathological characteristics and treatment strategies for patients with low-grade endometrial stromal sarcoma. Medicine. 2017;96(15):e6584. [crossref][PubMed]
Prat J. FIGO staging for uterine sarcomas. Int J Gynaecol Obstet. 2009;104(3):177-78.[crossref][PubMed]
Mbatani N, Olawaiye AB, Prat J. Uterine sarcomas. Int J Gynecol Obstet. 2018;143:51-58. [crossref][PubMed]
Berchuck A, Rubin SC, Hoskins WJ, Saigo PE, Pierce VK, Lewis JL Jr. Treatment of endometrial stromal tumours. Gynecol Oncol. 1990;36(1):60-65. [crossref][PubMed]
Leitao MM, Sonoda Y, Brennan MF, Barakat RR, Chi DS. Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus. Gynecol Oncol. 2003;91(1):209-12. [crossref][PubMed]
Noventa M, Gizzo S, Conte L, Dalla Toffola A, Litta P, Saccardi C. Fertility sparing surgery in young women affected by endometrial stromal sarcoma: an oncologic dilemma or a reliable option? Onco Targets Ther. 2015;8:29-35. Doi: 10.2147/ OTT.S69507. [crossref][PubMed]
Lindner T, Pink D, Kretzschmar A, Mrozek A, Thuss-Patience PC, Reichardt P. Hormonal treatment of endometrial stromal sarcoma: A po ssible indication for aromatase inhibitors. J Clin Oncol. 2005;23(16):9057. [crossref]
Dupont NC, Disaia PJ. Recurrent endometrial stromal sarcoma: Treatment with a progestin and GnRH agonist. Sarcoma. 2010;2010:353679.[crossref][PubMed]

DOI and Others

DOI: 10.7860/JCDR/2023/63730.18388

Date of Submission: Feb 27, 2023
Date of Peer Review: Apr 27, 2023
Date of Acceptance: Jun 23, 2023
Date of Publishing: Sep 01, 2023

• Financial or Other Competing Interests: None
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. Yes

• Plagiarism X-checker: Mar 07, 2023
• Manual Googling: May 13, 2023
• iThenticate Software: Jun 16, 2023 (10%)

ETYMOLOGY: Author Origin


JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)